Cargando…

Development and validation of the 40-item Glaucoma Visual Functioning Questionnaire

AIMS: To evaluate the psychometric properties of a newly designed questionnaire, the 40-item Glaucoma Visual Functioning Questionnaire (GVFQ-40), in a Chinese sample to capture the visual ability of patients with glaucomatous vision impairment in five domains. METHODS: Eighty-four glaucoma suspects...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Haishun, Lin, Junxiong, Luo, Man, Li, Zhidong, Zhu, Yingting, Han, Jiaxu, Jin, Ling, Li, Yiqing, Zhuo, Yehong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359518/
https://www.ncbi.nlm.nih.gov/pubmed/35379597
http://dx.doi.org/10.1136/bjophthalmol-2021-320985
_version_ 1785075900889432064
author Huang, Haishun
Lin, Junxiong
Luo, Man
Li, Zhidong
Zhu, Yingting
Han, Jiaxu
Jin, Ling
Li, Yiqing
Zhuo, Yehong
author_facet Huang, Haishun
Lin, Junxiong
Luo, Man
Li, Zhidong
Zhu, Yingting
Han, Jiaxu
Jin, Ling
Li, Yiqing
Zhuo, Yehong
author_sort Huang, Haishun
collection PubMed
description AIMS: To evaluate the psychometric properties of a newly designed questionnaire, the 40-item Glaucoma Visual Functioning Questionnaire (GVFQ-40), in a Chinese sample to capture the visual ability of patients with glaucomatous vision impairment in five domains. METHODS: Eighty-four glaucoma suspects (controls) and 270 glaucoma patients were recruited from the Glaucoma Clinic at Zhongshan Ophthalmic Centre in this cross-sectional, observational study. All subjects completed two questionnaires during routine clinical visits: the GVFQ-40 and the validated National Eye Institute Visual Functioning Questionnaire-25 (NEI VFQ-25). The discriminant, criterion-related and construct validity of the GVFQ-40 were assessed. A subset of subjects completed the GVFQ-40 twice, with an interval of 7–21 days, to determine test–retest reliability. RESULTS: Domain-specific and total GVFQ-40 scores were significantly higher (worse visual ability) in glaucoma patients than in controls (all p<0.001). All pairwise subgroup comparisons were statistically significant except for the ‘mobility’ domain comparison between the mild visual field loss and control groups (p=0.189). Significant differences between these two groups were observed in only 2 of the 12 dimensions on the NEI VFQ-25. The GVFQ-40 results demonstrated strong correlations with better-eye mean deviation and Visual Field Index (glaucoma severity measures). Exploratory factor analysis tended to confirm a three-domain structure. Test–retest intraclass correlation coefficients were higher than 0.927 for domain-specific and total GVFQ-40 scores. CONCLUSIONS: The GVFQ-40 possesses good validity and reliability. It can be used to evaluate the impact of glaucomatous damage on visual ability and has potential in the evaluation of intervention efficacy. TRIAL REGISTRATION NUMBER: NCT04722861.
format Online
Article
Text
id pubmed-10359518
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-103595182023-07-22 Development and validation of the 40-item Glaucoma Visual Functioning Questionnaire Huang, Haishun Lin, Junxiong Luo, Man Li, Zhidong Zhu, Yingting Han, Jiaxu Jin, Ling Li, Yiqing Zhuo, Yehong Br J Ophthalmol Clinical Science AIMS: To evaluate the psychometric properties of a newly designed questionnaire, the 40-item Glaucoma Visual Functioning Questionnaire (GVFQ-40), in a Chinese sample to capture the visual ability of patients with glaucomatous vision impairment in five domains. METHODS: Eighty-four glaucoma suspects (controls) and 270 glaucoma patients were recruited from the Glaucoma Clinic at Zhongshan Ophthalmic Centre in this cross-sectional, observational study. All subjects completed two questionnaires during routine clinical visits: the GVFQ-40 and the validated National Eye Institute Visual Functioning Questionnaire-25 (NEI VFQ-25). The discriminant, criterion-related and construct validity of the GVFQ-40 were assessed. A subset of subjects completed the GVFQ-40 twice, with an interval of 7–21 days, to determine test–retest reliability. RESULTS: Domain-specific and total GVFQ-40 scores were significantly higher (worse visual ability) in glaucoma patients than in controls (all p<0.001). All pairwise subgroup comparisons were statistically significant except for the ‘mobility’ domain comparison between the mild visual field loss and control groups (p=0.189). Significant differences between these two groups were observed in only 2 of the 12 dimensions on the NEI VFQ-25. The GVFQ-40 results demonstrated strong correlations with better-eye mean deviation and Visual Field Index (glaucoma severity measures). Exploratory factor analysis tended to confirm a three-domain structure. Test–retest intraclass correlation coefficients were higher than 0.927 for domain-specific and total GVFQ-40 scores. CONCLUSIONS: The GVFQ-40 possesses good validity and reliability. It can be used to evaluate the impact of glaucomatous damage on visual ability and has potential in the evaluation of intervention efficacy. TRIAL REGISTRATION NUMBER: NCT04722861. BMJ Publishing Group 2023-08 2022-04-04 /pmc/articles/PMC10359518/ /pubmed/35379597 http://dx.doi.org/10.1136/bjophthalmol-2021-320985 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Clinical Science
Huang, Haishun
Lin, Junxiong
Luo, Man
Li, Zhidong
Zhu, Yingting
Han, Jiaxu
Jin, Ling
Li, Yiqing
Zhuo, Yehong
Development and validation of the 40-item Glaucoma Visual Functioning Questionnaire
title Development and validation of the 40-item Glaucoma Visual Functioning Questionnaire
title_full Development and validation of the 40-item Glaucoma Visual Functioning Questionnaire
title_fullStr Development and validation of the 40-item Glaucoma Visual Functioning Questionnaire
title_full_unstemmed Development and validation of the 40-item Glaucoma Visual Functioning Questionnaire
title_short Development and validation of the 40-item Glaucoma Visual Functioning Questionnaire
title_sort development and validation of the 40-item glaucoma visual functioning questionnaire
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359518/
https://www.ncbi.nlm.nih.gov/pubmed/35379597
http://dx.doi.org/10.1136/bjophthalmol-2021-320985
work_keys_str_mv AT huanghaishun developmentandvalidationofthe40itemglaucomavisualfunctioningquestionnaire
AT linjunxiong developmentandvalidationofthe40itemglaucomavisualfunctioningquestionnaire
AT luoman developmentandvalidationofthe40itemglaucomavisualfunctioningquestionnaire
AT lizhidong developmentandvalidationofthe40itemglaucomavisualfunctioningquestionnaire
AT zhuyingting developmentandvalidationofthe40itemglaucomavisualfunctioningquestionnaire
AT hanjiaxu developmentandvalidationofthe40itemglaucomavisualfunctioningquestionnaire
AT jinling developmentandvalidationofthe40itemglaucomavisualfunctioningquestionnaire
AT liyiqing developmentandvalidationofthe40itemglaucomavisualfunctioningquestionnaire
AT zhuoyehong developmentandvalidationofthe40itemglaucomavisualfunctioningquestionnaire